Abstract
Background Referred sensation (RS) is described as the sensation evoked in the skin areas other than the stimulated region. The aim of the study was to identify and map RS in traumatic brachial plexus injury (TBPI) patients through a standardised assessment.
Methods In Experiment 1, 12 patients underwent an RS screening by stimulating 22 skin areas distributed in both upper limbs, neck, and face with a cotton swab. In Experiment 2, a detailed RS mapping employing Semmes-Weinstein monofilament was performed at the reinnervated forearm of three subjects who showed RS in experiment 1 screening. In one of these patients, RS mapping was performed over a time span of 6.3 years.
Results Screening of TBPI patients submitted to different reconstructive surgeries revealed RS only in the patients who underwent intercostal to musculocutaneous nerve (ICN-MCN) transfer. RS systematic mapping of these patients revealed a unique distribution in the forearm and the chest, without any clear topographic organisation. Longitudinal assessment in one of the tested participants showed a scattered expansion of the RS throughout time.
Conclusions This is the first study to map systematically the RS in patients with TBPI. RS was identified only after ICN-MCN transfer. A possible explanation for this phenomenon is that the greater distance between the representations of the donor and receptor nerves at the primary somatosensory cortex (S1) could constrain plastic reorganisation and thus limit the disentangling of the forearm and chest sensations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was produced as part of the activities of the Research, Innovation and Dissemination Center for Neuromathematics-CEPID, NeuroMat (grant #2013/ 07699-0), S.Paulo Research Foundation (FAPESP) and by the Brain Plasticity after Brachial Plexus Injury projects (FAPERJ #E26/010002474/2016, CNE #202.785/2018 and #E-26/010.002418/2019). It also received funding from FINEP (PROINFRA HOSPITALAR #18.569-8) and was also supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant #310397/2021). A.C.S was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (grant #88887.511155/2020-00). B.L.R. was supported by the CNPq (grant #141723/2015-7) and FAPESP (grant #2022/00582-9).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the Institute of Neurology Deolindo Couto-UFRJ, Brazil gave ethical approval for this work (process number: 298.925)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors